Optimizing Critical Care for the Obese Population: From Physiology to Practice

Argoseto Argoseto

Abstract

Background
Obesity poses distinct issues in the Intensive Care Unit (ICU) owing to its related physiological changes, comorbidities, and the intricacies of management. Obese individuals face heightened risks for respiratory problems, cardiovascular issues, and metabolic dysregulation.
Content
Effective management necessitates customized strategies: Respiratory Support: Elevated positive end-expiratory pressure (PEEP), prone positioning, as well as tailored ventilatory modifications are crucial for managing impaired breathing mechanics and averting lung injury. Hemodynamic Management: Careful fluid management and non-invasive monitoring are needed to address altered cardiovascular dynamics and optimize perfusion. Pharmacologic Adjustments: Dosage modifications for sedatives, analgesics, and vasoactive agents accommodate altered drug metabolism and distribution. Nutritional Support: Hypocaloric, high-protein feeding is advised to meet energy needs while avoiding overfeeding, ideally guided by indirect calorimetry. Thromboprophylaxis and Mobility: Heightened risk for venous thromboembolism (VTE) requires higher anticoagulant doses and early mobilization using bariatric equipment. Furthermore, obesity can also caused obesity paradox, an unexpected survival benefit in septic patients with obesity, likely due to enhanced energy reserves, RAAS activation, and anti-inflammatory effects.
Summary
A multidisciplinary and individualized approach is critical to improving outcomes in obese ICU patients, highlighting the need for updated clinical guidelines and further research tailored to this population.

Keywords

Hemodynamic, ICU, Obesity, Respiratory, Ventilator

Full Text:

PDF

References

Kalani C, Venigalla T, Bailey J, Udeani G, Surani S. Sepsis Patients in Critical Care Units with Obesity: Is Obesity Protective? Cureus [Internet]. 2020 Feb 10 [cited 2025 Jul 16]; Available from: https://www.cureus.com/articles/27785-sepsis-patients-in-critical-care-units-with-obesity-is-obesity-protective

Peters U, Dixon AE. The effect of obesity on lung function. 2019;

Thota B, Jan KM, Oh MW, Moon TS. Airway management in patients with obesity. Saudi J Anaesth. 2022 Jan;16(1):76–81.

National Academies of Sciences E, Division H and M, Board F and N, Solutions R on O, Nicholson A. Current State of Pharmacokinetics and Pharmacology for Obesity. In: Medications and Obesity: Exploring the Landscape and Advancing Comprehensive Care: Proceedings of a Workshop [Internet]. National Academies Press (US); 2024 [cited 2025 Jul 16]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK609406/

Ghimire P, Sankari A, Antoine MH, Bollu PC, Kaul P. Obesity-Hypoventilation Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jul 16]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK542216/

Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020 Feb;9(1):80–93.

Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2021 May 25 [cited 2025 Jul 16];143(21). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000973

Chandrasekaran P, Weiskirchen R. The Role of Obesity in Type 2 Diabetes Mellitus—An Overview. Int J Mol Sci. 2024 Feb 4;25(3):1882.

Stadler JT, Lackner S, Mörkl S, Trakaki A, Scharnagl H, Borenich A, et al. Obesity Affects HDL Metabolism, Composition and Subclass Distribution. Biomedicines. 2021 Feb 27;9(3):242.

Latos M, Szymczak A, Solecki M. Intravenous access in patients with morbid obesity. Surg Vasc Nurs. 2024;18(2):71–4.

De Jong A, Wrigge H, Hedenstierna G, Gattinoni L, Chiumello D, Frat JP, et al. How to ventilate obese patients in the ICU. Intensive Care Med. 2020 Dec;46(12):2423–35.

Hasanin A, Tarek H, Mostafa MMA, Arafa A, Safina AG, Elsherbiny MH, et al. Modified-ramped position: a new position for intubation of obese females: a randomized controlled pilot study. BMC Anesthesiol [Internet]. 2020 Dec [cited 2025 Jul 19];20(1). Available from: https://bmcanesthesiol.biomedcentral.com/articles/10.1186/s12871-020-01070-2

Gaszynski T, McKechnie A. Pre-oxygenation and apneic oxygenation in patients living with obesity – A review of novel techniques. Saudi J Anaesth. 2022 Jul;16(3):322–6.

Oh C, Chung W, Hong B. A simple equation for ideal body weight. Eur J Anaesthesiol EJA. 2021 Jun;38(6):671.

Gouju J, Legeay S. Pharmacokinetics of obese adults: Not only an increase in weight. Biomed Pharmacother. 2023 Oct;166:115281.

Bianchettin RG, Lavie CJ, Lopez-Jimenez F. Challenges in Cardiovascular Evaluation and Management of Obese Patients. J Am Coll Cardiol. 2023 Feb;81(5):490–504.

Cai A, Liu L, Zhou D, Tang S, Tadic M, Schutte AE, et al. Obesity and Risk of Incident Left Ventricular Hypertrophy in Community‐Dwelling Populations With Hypertension: An Observational Study. J Am Heart Assoc [Internet]. 2024 Jun 18 [cited 2025 Jul 21];13(12). Available from: https://www.ahajournals.org/doi/10.1161/JAHA.123.033521

Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M, et al. The Impact of Obesity on the Cardiovascular System. J Diabetes Res. 2018 Nov 4;2018:1–12.

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181–247.

Zhang Y, Wang M, Lu Z, Yang M. Effect of Fluid Resuscitation Strategies for Obese Patients with Sepsis and Septic Shock: A Systematic Review. Intensive Care Res. 2022 Oct 27;3(1):61–8.

Erstad BL, Barletta JF. Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis. Crit Care [Internet]. 2021 Feb 23 [cited 2025 Jul 16];25(1). Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-021-03495-8

Ynineb AR, Yumuk E, Copot D, Ayvaz B, Khoumeri B, Othman GB, et al. memory effects in obese patients using fractional and augmented. Sci Rep. 2025;

Zhou Q, Pan S dong, Zhu L ling, Chen M, Xia P. Weight-based dosing in medication use: what should we know? Patient Prefer Adherence. 2016 Apr;549.

May M, Schindler C, Engeli S. Modern pharmacological treatment of obese patients. Ther Adv Endocrinol Metab. 2020;

Singh B, Cusick AS, Goyal A, Patel P. ACE Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jul 22]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430896/

Giusti EM, Spatola CAM, Brunani A, Kumbhare D, Oral A, Ilieva E, et al. International Society of Physical and Rehabilitation Medicine/European Society of Physical and Rehabilitation Medicine Guidelines on Physical and Rehabilitation Medicine Professional Practice for Adults with Obesity and Related Comorbidities. J Int Soc Phys Rehabil Med. 2020;3(1):11–21.

De Waele E, Jakubowski JR, Stocker R, Wischmeyer PE. Review of evolution and current status of protein requirements and provision in acute illness and critical care. Clin Nutr. 2021 May;40(5):2958–73.

Dickerson RN, Andromalos L, Brown JC, Correia MITD, Pritts W, Ridley EJ, et al. Obesity and critical care nutrition: current practice gaps and directions for future research. Crit Care [Internet]. 2022 Sep 20 [cited 2025 Jul 22];26(1). Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-022-04148-0

Frenette A, Gershkovich B, Castellucci LA, Patel RV. Venous thromboembolism prophylaxis in obese, critically-ill patients: A survey of Ottawa region Intensivists. Thromb Res. 2020 Feb;186:42–4.

Raya-Benítez J, Heredia-Ciuró A, Calvache-Mateo A, Martín-Núñez J, Valenza-Peña G, López-López L, et al. Effectiveness of non-instrumental early mobilization to reduce the incidence of deep vein thrombosis in hospitalized patients: A systematic review and meta-analysis. Int J Nurs Stud. 2025 Jan;161:104917.

Schaefer JK, Errickson J, Kong X, Ali MA, Chipalkatti N, Haymart B, et al. A Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism. JACC Adv. 2025 May;4(5):101714.

Sorodoc V, Asaftei A, Ceasovschih A, Lionte C, Crisan S, Constantin M, et al. Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management. Front Pharmacol. 2024 Dec 17;15:1457280.

DOI: https://doi.org/10.20961/soja.v6i1.108499

Refbacks

  • There are currently no refbacks.